Immediate Impact
58 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Libing Xiang being referenced
The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
2018
Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Libing Xiang | 210 | 96 | 105 | 213 | 195 | 42 | 592 | |
| Katharina Prieske | 193 | 87 | 142 | 159 | 157 | 48 | 516 | |
| Cláudio Galleano Zettler | 185 | 53 | 130 | 157 | 148 | 37 | 570 | |
| Sally Baron‐Hay | 365 | 200 | 78 | 85 | 231 | 44 | 734 | |
| Louise De Brot | 169 | 176 | 107 | 149 | 131 | 50 | 558 | |
| Maxine L. Crook | 134 | 197 | 81 | 102 | 209 | 35 | 604 | |
| Go Eun Bae | 142 | 41 | 101 | 84 | 133 | 43 | 515 | |
| Maria Elena Guerrieri | 166 | 157 | 124 | 137 | 110 | 27 | 514 | |
| Carla Bartosch | 148 | 235 | 86 | 118 | 172 | 57 | 700 | |
| Yalan Bi | 216 | 131 | 128 | 86 | 156 | 49 | 698 | |
| Yasunori Hashiguchi | 226 | 187 | 71 | 81 | 233 | 36 | 535 |
All Works
Login with ORCID to disown or claim papers
Loading papers...